An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.
The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.
References
Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).
Recent Posts
Academy Submits Comments on Proposed Revisions to MPFS CY 2026
In response to the Centers for Medicare and Medicaid Services (CMS) Notice of Proposed Rulemaking (NPRM) regarding revisions to Medicare payment policies under the Medicare…
CDC Director Monarez Fired
On August 27, the Centers for Disease Control and Prevention (CDC) Director Susan Monarez was abruptly fired after serving less than a month in her…
Congratulations to Our 2025 Scholarship Recipients
The American Academy of Audiology Foundation’s mission is to promote philanthropy in support of public awareness, research, and education in audiology and hearing and balance…